glp-1 obesity drugs news today Weight Loss There's been a 1,500% increase

Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells

Includes PREDIMED data and EU health claim context.

They modulate central neural pathways and peripheral metabolic processes, providing cardiometabolic benefits beyond weight reduction

Compare early results with Wegovy and Mounjaro.

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.